Thousands of Actos bladder cancer lawsuits are pending in federal and state courts throughout the United States. However, Actos sales – and injuries – are global. In fact, over 1.7 million Actos prescriptions were filled in Australia alone over the past four years. Now, Australia residents are suing Takeda over Actos bladder cancer injuries.
Down Under Takes Front & Center
According to a recent article in The Sydney Morning Herald, Takeda’s diabetes drug Actos has been prescribed more than 1.7 million times to Australians over the past four years, and increasing numbers of users have reported suffering from serious Actos side effects, such as bladder cancer, during that time. While thousands of U.S. lawsuits are pending against the Japanese-based manufacturer, Takeda Pharmaceuticals, Australians injured by Actos have stated that they will join a U.S. class action lawsuit against Takeda and its co-manufacturer Eli Lilly.
Where Will Actos Bladder Cancer Litigation Go?
That’s a question everyone wants answered. The first Actos bladder cancer lawsuit to go to trial resulted in a $6.5 million jury verdict for the plaintiff. Although that verdict was recently overturned on technical grounds specific to that individual lawsuit, plaintiffs’ attorneys say that the damaging evidence against the manufacturers about what they knew, when they knew it and their failure to warn consumers of known risks may result in similar verdicts in the future that will not be overturned.
If you or a loved one has been diagnosed with bladder cancer after taking Actos, contact The Driscoll Firm, LLC, to discuss your situation and let us determine whether you may be entitled to compensation for your injury-related medical bills, medical monitoring, lost income, physical and emotional pain and suffering and more. Initial consultations are free of charge, without further obligation and are intended to give you the information you need to decide whether taking legal action makes sense for you and your family.